Craig Kornick

Summary

Publications

  1. ncbi A safe and effective method for converting patients from transdermal to intravenous fentanyl for the treatment of acute cancer-related pain
    Craig A Kornick
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 97:3121-4. 2003
  2. ncbi QTc interval prolongation associated with intravenous methadone
    Craig A Kornick
    Pain and Palliative Care Service, Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Pain 105:499-506. 2003
  3. ncbi Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain
    Craig A Kornick
    Department of Neurology, Memorial Sloan Kettering Cancer Center, Pain and Palliative Care Service, New York, New York, USA
    Drug Saf 26:951-73. 2003
  4. ncbi Complications of lumbar facet radiofrequency denervation
    Craig Kornick
    Department of Anesthesiology, Division of Pain Management, Mayo Clinic, Jacksonville, Florida, USA
    Spine (Phila Pa 1976) 29:1352-4. 2004
  5. ncbi Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain
    Natalie Moryl
    Pain and Palliative Care Service, Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Pain 96:325-8. 2002
  6. ncbi Olanzapine in the management of cancer pain
    Natalia Khojainova
    Pain and Palliative Care Service, Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    J Pain Symptom Manage 23:346-50. 2002
  7. ncbi Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents
    Alexander N Katchman
    Department of Pharmacology, Georgetown University Medical Center, 3900 Reservoir Road NW, Washington, DC 20007, USA
    J Pharmacol Exp Ther 303:688-94. 2002

Collaborators

Detail Information

Publications7

  1. ncbi A safe and effective method for converting patients from transdermal to intravenous fentanyl for the treatment of acute cancer-related pain
    Craig A Kornick
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 97:3121-4. 2003
    ..Patients at the authors' institution routinely are switched from transdermal to intravenous (IV) fentanyl using a 1:1 (transdermal:IV) conversion during severe episodes of pain...
  2. ncbi QTc interval prolongation associated with intravenous methadone
    Craig A Kornick
    Pain and Palliative Care Service, Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Pain 105:499-506. 2003
    ..Methadone in combination with chlorobutanol is associated with QTc interval prolongation. Our data strongly suggest that methadone in combination with chlorobutanol is associated with QTc interval prolongation...
  3. ncbi Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain
    Craig A Kornick
    Department of Neurology, Memorial Sloan Kettering Cancer Center, Pain and Palliative Care Service, New York, New York, USA
    Drug Saf 26:951-73. 2003
    ..Patients may resume such activities once the absence of these potential adverse effects is documented...
  4. ncbi Complications of lumbar facet radiofrequency denervation
    Craig Kornick
    Department of Anesthesiology, Division of Pain Management, Mayo Clinic, Jacksonville, Florida, USA
    Spine (Phila Pa 1976) 29:1352-4. 2004
    ..Retrospective...
  5. ncbi Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain
    Natalie Moryl
    Pain and Palliative Care Service, Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Pain 96:325-8. 2002
    ..A uniformly accepted conversion ratio for substituting methadone with another opioid is currently not available. More data on the rotation from methadone to other opioids are needed...
  6. ncbi Olanzapine in the management of cancer pain
    Natalia Khojainova
    Pain and Palliative Care Service, Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    J Pain Symptom Manage 23:346-50. 2002
    ..We conclude that olanzapine may be useful in the treatment of patients with uncontrolled cancer pain associated with cognitive impairment or anxiety. Further studies to evaluate possible analgesic effect of olanzapine are needed...
  7. ncbi Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents
    Alexander N Katchman
    Department of Pharmacology, Georgetown University Medical Center, 3900 Reservoir Road NW, Washington, DC 20007, USA
    J Pharmacol Exp Ther 303:688-94. 2002
    ....